1. [ACMG](http://www.nature.com/gim/journal/v15/n9/full/gim201392a.html) clinical laboratory standards for next-generation sequencing, Genetics in Medicine, 2013. [Standards and guidelines for the interpretation of sequence variants](http://www.nature.com/gim/journal/v17/n5/full/gim201530a.html): a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, 2015
2. [A systematic approach](http://onlinelibrary.wiley.com/doi/10.1111/cge.12257/abstract) to assessing the clinical significance of genetic variants, Clin Genet, 2013.
3. Assuring the quality of next-generation sequencing in [clinical laboratory practice](http://www.nature.com/nbt/journal/v30/n11/full/nbt.2403.html), Nature Biotechnology, 2012.
4. Development and validation of [a clinical cancer genomic profiling test](http://www.nature.com/nbt/journal/v31/n11/full/nbt.2696.html) 
based on massively parallel DNA sequencing, Nature Biotechnology, 2013.
5. Tumour heterogeneity [in the clinic](http://www.nature.com/nature/journal/v501/n7467/full/nature12627.html), Nature, 2013, More [insights](http://www.nature.com/nature/supplements/insights/tumour_heterogeneity/).
6. Implementing personalized cancer genomics [in clinical trials](http://www.nature.com/nrd/journal/v12/n5/abs/nrd3979.html), NR Drug Discovery, 2013.
7. Genomics in Clinical Practice: [Lessons from the Front Lines](http://stm.sciencemag.org/content/5/194/194cm5.full), Science Translational Medicine, 2013.
8. Next-generation sequencing [in the clinic](http://www.nature.com/nbt/journal/v31/n11/full/nbt.2743.html), Nature Biotechnology, 2013.
9. [Individualized Medicine](http://www.sciencedirect.com/science/article/pii/S0092867414002049) from Prewomb to Tomb, *Cell*, 2014.
10. Designing Transformative Clinical Trials in [the Cancer Genome Era](http://jco.ascopubs.org/content/31/15/1834.full), ACO, 2013.
11. [Guidelines](http://www.nature.com/nature/journal/v508/n7497/full/nature13127.html) for investigating causality of sequence variants in human disease, Nature, 2014.
12. Next-generation sequencing [in the clinic](http://www.nature.com/nrg/journal/v13/n11/full/nrg3357.html): are we ready? Nature, 2012.
13. Next-generation sequencing in the clinic: [Promises and challenges](http://www.sciencedirect.com/science/article/pii/S0304383512006726), *Cell*, 2013
14. American Society of Clinical Oncology [Policy Statement Update](http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.63.0996): Genetic and Genomic Testing for Cancer Susceptibility, JCO, 2015. 
[Template](http://www.archivesofpathology.org/doi/10.5858/arpa.2014-0588-CP) for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System. 
15. Web focuses [personalized medicine](http://www.nature.com/nrclinonc/focus/personalized-medicine/index.html) (**4P**), NRCO, 2012
16. Translational research in oncology - 10 years of progress and future prospects - [Human tumour tissue-based experimental therapeutics for cancer](http://www.nature.com/nrclinonc/journal/v11/n11/full/nrclinonc.2014.158.html), NRCO, 2014
17. Cancer Systems Biology: [a peek](http://www.nature.com/nrclinonc/journal/v11/n3/full/nrclinonc.2014.6.html) into the future of patient care? NRCO, 2014
18. [Pragmatic issues](http://www.nature.com/nrclinonc/journal/v12/n4/full/nrclinonc.2014.202.html) in biomarker evaluation for targeted therapies in cancer (major challenges), NRCO, 2015
19. Cancer Genome Landscapes - [Cancer Genomics](http://www.sciencemag.org/site/special/cancergenomics/index.xhtml), Science, 2013.
20. [Principles and methods](http://www.nature.com/nrc/journal/v14/n5/full/nrc3721.html) of integrative genomic analyses in cancer, Nature Review Cancer, 2014. Methods of integrating data to uncover [genotypeâ€“phenotype interactions](http://www.nature.com/nrg/journal/v16/n2/full/nrg3868.html), NRG, 2015
21. [Diagnostic genomics](http://www.genomemedicine.com/series/diagnostics?from=timeline&isappinstalled=0) on Genome Medicine since Jan, 2015. Some elite [collection](https://pantheonofarticles.wordpress.com/) by Dr. Zheng
22. [Genetic counseling](https://en.wikipedia.org/wiki/Genetic_counseling) can be separated into diagnostic and supportive aspects. Associated journal [Journal of Genetic Counseling](http://link.springer.com/journal/volumesAndIssues/10897) and Nature comments [Genetics: Fluent in DNA](http://www.nature.com/nature/journal/v526/n7571/full/nj7571-151a.html)
23. Health [ROI](http://www.nature.com/nbt/journal/v33/n8/full/nbt.3276.html) as a measure of misalignment of biomedical needs and resources, Nature Biotechnology, 2015. 
24. [Protective alleles and modifier variants](http://www.nature.com/nrg/journal/vaop/ncurrent/full/nrg4017.html) in human health and disease, NRG, 2015. Return of genetic testing results in the era of whole-genome sequencing ([WGS](http://www.nature.com/nrg/journal/v16/n9/full/nrg3960.html)), NRG, 2015. The support of human genetic evidence for [approved drug indications](http://www.nature.com/ng/journal/v47/n8/full/ng.3314.html), NG, 2015.
25. Challenges and prospects for biomarker research: [A current perspective from the developing world](http://www.sciencedirect.com/science/article/pii/S1570963914000028), Next-generation clinical trials: [Novel strategies](http://www.sciencedirect.com/science/article/pii/S157478911400235X) to address the challenge of tumor molecular heterogeneity, 2014.
26. [Big Data in Biomedicine](http://www.nature.com/nature/outlook/big-data/), Nature **OUTLOOK**, Informatics: Make sense of health data, [N & C](http://www.nature.com/news/informatics-make-sense-of-health-data-1.18691), 2015. 
27. [Cancer Genomics in Clinical Context](http://www.cell.com/trends/cancer/issue?pii=S2405-8033(15)X0002-1), [chi](http://www.ebiotrade.com/newsf/2015-9/2015930110911443.htm), first vol in *Trends in Cancer*, 2015.
28. [ClinGen](http://www.nejm.org/doi/full/10.1056/NEJMsr1406261) - The Clinical Genome Resource, NEJM, 2015; [Germline Mutations in Predisposition Genes in Pediatric Cancer](http://www.nejm.org/doi/full/10.1056/NEJMoa1508054), [chi-1](http://mp.weixin.qq.com/s?__biz=MzA5NTYzMzAyNQ==&mid=400458328&idx=2&sn=fd5118e3c5a4ae01f44dcbb676080d46&scene=0&uin=Njg2NTk3MzAx&key=d72a47206eca0ea91b49e418660000a30784de6f84e1ed91bd0b6835ef8769fbeb008c37d106e7aeaf9f353dee0ef131&devicetype=webwx&version=70000001&lang=zh_CN&pass_ticket=yLFtjDmSRkZh24MxnB8ShWXNRbT9jzRQyOKO%2BS9DKXGYsxSjYBznIklNzZvOECNE), [chi-2](http://mp.weixin.qq.com/s?__biz=MjM5MDIxNTQ4MA==&mid=401845614&idx=1&sn=81e74a384984d1257b5a337440b964bf&scene=0&uin=Njg2NTk3MzAx&key=d72a47206eca0ea9ecdfec088dc261266a288ecb9199f536b35970dfa61491248bc98232a16e247e77dd12895a6cfb08&devicetype=webwx&version=70000001&lang=zh_CN&pass_ticket=yLFtjDmSRkZh24MxnB8ShWXNRbT9jzRQyOKO%2BS9DKXGYsxSjYBznIklNzZvOECNE), NEJM, 2015.
